The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study.
 
Anita Lavery
Travel, Accommodations, Expenses - Ipsen; SERVIER
 
Leanne Stevenson
No Relationships to Disclose
 
Damian McManus
No Relationships to Disclose
 
Gemma E. Logan
Employment - Almac Diagnostics
 
Steven M. Walker
Employment - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - Named inventor on Almac Diagnostics patents
 
Gera L. Jellema
No Relationships to Disclose
 
Sandra Van Schaeybroeck
No Relationships to Disclose
 
Pradeep Singh Virdee
No Relationships to Disclose
 
Leena Elhussein
No Relationships to Disclose
 
Julie Turbitt
No Relationships to Disclose
 
Diane Colinson
No Relationships to Disclose
 
Zofia Miedzybrodzka
Honoraria - Akcea Therapeutics; MSD
Research Funding - Akcea Therapeutics; AstraZeneca; Chiesi; Sanofi
 
Russell D. Petty
Honoraria - Bristol-Myers Squibb; Lilly; Pfizer; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Pfizer; Sanofi
Research Funding - AstraZeneca; Boston Biomedical; Clovis Oncology; Five Prime Therapeutics; Janssen; Lilly; Merck Serono; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly
 
Paul D. Harkin
Employment - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - Almac Diagnostics
 
Richard D. Kennedy
Employment - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - Almac Diagnostics
Travel, Accommodations, Expenses - Almac Diagnostics
 
Martin McKinlay Eatock
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; SERVIER
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Merck
 
Mark R. Middleton
Consulting or Advisory Role - BiolineRx; Bristol-Myers Squibb; Immunocore; Johnson & Johnson; Merck; Vaccitech; Vista Pharmacueticals
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Vertex (Inst)
(OPTIONAL) Uncompensated Relationships - GenesisCare
 
Anne L. Thomas
Consulting or Advisory Role - Amgen; Pierre Fabre
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Amgen; Bristol-Myers Squibb; SERVIER
 
Richard C. Turkington
Consulting or Advisory Role - Almac Diagnostics
Patents, Royalties, Other Intellectual Property - Patent for the DNA Damage Immune Response Assay in Oesophageal Cancer